Results 261 to 270 of about 79,953 (279)
Some of the next articles are maybe not open access.

Sudden Death by AL Amyloidosis

American Journal of Forensic Medicine & Pathology, 2023
Abstract We report the case of a young female that died due to systemic amyloidosis.
Christian, Perez, Kristy, Waite
openaire   +2 more sources

Macroglossia – not always AL amyloidosis

Amyloid, 2010
Abstract Abstract 5007 Introduction: Amyloidosis is characterized by extracellular deposition of abnormal insoluble fibrillar proteins. The two most frequent systemic amyloidoses are the light-chain (AL amyloidosis) and familial transthyretin (ATTR) forms.
Andrew J, Cowan   +6 more
openaire   +2 more sources

Primary amyloidosis (AL) in families

American Journal of Hematology, 1986
AbstractWe report the occurrence of immunoglobulin‐related amyloidosis (AL) in three separate families, each family having two members affected. None of the six patients had evidence to suggest the presence of familial amyloidosis (AF). Previously, immunoglobulin‐related amyloidosis (AL) was considered to be a sporadic disease process.
M A, Gertz, J P, Garton, R A, Kyle
openaire   +2 more sources

[AL amyloidosis].

Revue medicale de Bruxelles, 2001
AL amyloidosis is a systemic disease caused by the deposition of fibrillar proteins in organs and tissues. These deposits are responsible for organic dysfunctions and may be rapidly lethal. Current therapy is unsatisfactory. We describe three clinical cases of multisystemic AL amyloidosis but with different initial presentation: nephrotic syndrome ...
A R, Hedeshi   +6 more
openaire   +1 more source

Monoclonal IgM-related AL amyloidosis

Best Practice & Research Clinical Haematology, 2016
Monoclonal immunoglobulin M (IgM)-related light chain (AL) amyloidosis, which accounts for 5%-7% of all AL amyloidosis cases, is a distinct clinical entity that poses specific challenges to clinicians. Several studies reported that although there is a substantial overlap, the pattern of organ involvement is peculiar, with higher frequencies of lung ...
Milani P., Merlini G.
openaire   +3 more sources

Amyloidosis (AL)

Archives of Internal Medicine, 1984
[ill]myloidosis is considered by many to be a rare disease. In a retrospective review by Alexanian al in this issue,130 cases of amyloidosis were [ill]gnosed during a 15-year span. Because symptoms [ill]re present for 20 months before diagnosis, the [ill]hors point out the need for better identification [ill]d earlier diagnosis.
openaire   +2 more sources

Immunomodulatory drugs in AL amyloidosis

Critical Reviews in Oncology/Hematology, 2016
Immunoglobulin light chain amyloidosis (AL amyloidosis) is indeed a rare plasma cell disorder, yet the most common of the systemic amyloidoses. The choice of adequate treatment modality is complicated and depends dominantly on the risk stratification of these fragile patients.
T, Jelinek, Z, Kufova, R, Hajek
openaire   +2 more sources

AL amyloidosis

Medicine, 2021
Samir Asher, Majid Kazmi
openaire   +1 more source

[AL amyloidosis].

Nihon rinsho. Japanese journal of clinical medicine, 1995
AL amyloidosis is one type of systemic amyloidosis. AL represents Amyloid of Light chains (of Ig's) type. Diagnosis of amyloid must be carried out by patho-histological Congo-red stains of the biopsied materials under suspicion of amyloid deposits from patients with various clinical manifestations, including macroglossia, cardiac abnormalities, ECG ...
openaire   +1 more source

AL amyloidosis.

The Journal of the Association of Physicians of India, 2013
Susanta Kr, Das   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy